K

Krebs Biochem

(NSE: KREBSBIO)

KREBSBIO

111.35

0.00 (0.00%)

Krebs Biochem Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Krebs Biochem Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Krebs Biochem Price Summary

Today High

114.6

Today Low

109.65

52 Week High

114.6

52 Week Low

109.65

Krebs Biochem Fundamentals

Market Cap

323.4 Cr

CASA

0.0

No. Of Shares

2.2 Cr

P/E

0.0

P/B

-3.7

Face Value

10.0

Dividend Yeild

0.0

Book Value

-23.9

Net Interest Income

7.2

Cost to Income

NA

Promoter Holdings

72.7

EPS

-14.5

CAR

NA

ROE

0.0

ROCE

-44.3

Profit Growth

NA

Krebs Biochem Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Krebs Biochem

111.35

323.4 Cr

-3.7

0.0

-14.5

0.0

-44.3

7.2

Albert David

553.55

326.7 Cr

0.9

9.7

38.8

9.5

12.0

316.5

Ind-Swift Labs

56.2

333.5 Cr

1.0

0.0

-0.7

-1.0

8.2

51.3

Kilitch Drugs

166

300.0 Cr

0.8

20.4

4.0

3.9

4.9

177.3

Venus Remedies

204.25

385.9 Cr

0.9

6.2

44.0

15.1

10.8

12.2

Wanbury

62

256.4 Cr

-1.6

0.0

-5.0

0.0

46.9

40.2

FAQ’s on Krebs Biochem

About Krebs Biochem

Krebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the last decade.

KBIL went into public in the year March 1994 to part finance its fermentation technology project. KBIL has a strong shareholding community of over 10000 spread across all parts of the country.

KBIL’s manufacturing Unit-I is located at Regadichelika Village, Nellore Dist., Andhra Pradesh, India. Products manufactured from Unit I facility are Ephedrine, Pseudoephedrine and their salts, which are used for making formulations for respiratory ailments, viz., cough, cold etc.

The facility at Unit II is being used to manufacture a basket of fermentation products viz., Lovastatin, Simvastatin, (all cholesterol reducing agents) and Vitamin C and its salts (neutraceuticals), which has wider applications in pharma, feeds, foods beverages etc. The company is focussing on the research and development of new bio molecules and genetically engineered products by synthetic and biological approaches. The manufacturing facility is developed in an area of 83.79 acres and comprises of Administration Block, Fermentation Block, Extraction Column, Hydrogenation & Synthetic Blocks, Quality Control Department, Quality Assurance Block, Ware House, Pseudoephedrine Block, Solvent Yard and Canteen etc.

KBIL has received ISO 9002 certification for its Unit-I situated at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services (U.K.A.S.) in the year 2001. Unit I is also accredited with European Certificate of Suitability from European Directorate for the Quality of Medicines (EDQM).

Product range of the company includes:

Bulk activities

Synthetic

  • Lavastatin
  • Simvastatin
  • I -Ephedrochiloride
  • l - Ephedrine Sulphate
  • l - Ephedrine Base (Liquid)
  • d - Pseudoephedrine Hydrochloride
  • d - Pseudoephedrine Sulphate
  • d - Pseudoephedrine Base
  • dl - Ephedrine Base
  • n - Methyl Ephedrine
  • d - Ephedrine Bitartarate
  • Vitamin C
  • Vitamin C (Coated)

Herbal

  • Calcium Sennosides - 20% & 60%
  • Garcinia Combogia Powdered Extract
  • Capsaicin - 50/100

Intermediates

  • Crude Lovastatin
  • Simvastatin Ammonium Salt

Products in pipeline

  • Pravastatin Sodium

Achievements/ recognition:

  • ISO 9002 in November 2001 
  • EDQM July 2003 
  • USFDA in November 2003 
  • ISO 9001 – 2000 in March 2004 
  • WHO GMP certification in November 2002 and renewed in March 2005

Trade Krebs Biochem today

Create a free portfolio in Trinkerr and earn and grow along with peers